Disc Medicine (IRON) Other Working Capital Changes (2022 - 2026)
Disc Medicine's (IRON) quarterly Other Working Capital Changes came in at -$168000.0 in Q1 2026, down 138.62% year-on-year from $435000.0 in Q1 2025, and down 1.82% on a QoQ basis from -$165000.0 in Q4 2025.
Disc Medicine (IRON) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Disc Medicine (IRON) has 5 years of Other Working Capital Changes data on file, last reported at -$168000.0 in Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 138.62% year-over-year to -$168000.0 in Q1 2026; TTM through Mar 2026 was -$417000.0, a 2880.0% decrease from a year earlier, with the FY2025 full-year figure at $186000.0, up 137.58% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$168000.0, down from -$165000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for IRON reached as high as $7.2 million in Q1 2025 and fell as low as -$2.5 million in Q2 2024.
- Historically, Other Working Capital Changes has averaged $764647.1 across 5 years, with a median of $64000.0 in 2022.
- Across the five-year window, Other Working Capital Changes slumped 476.47% in 2023 and soared 680.0% in 2025, its largest moves.
- Year by year, Other Working Capital Changes stood at -$73000.0 in 2022, then jumped by 146.58% to $34000.0 in 2023, then plunged by 423.53% to -$110000.0 in 2024, then slumped by 50.0% to -$165000.0 in 2025, then fell by 1.82% to -$168000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$168000.0 in Q1 2026, -$165000.0 in Q4 2025, and -$156000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Disc Medicine | 2.90 Bn | 2.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -168,000.00 |
| Mar 31, 2026 | -168,000.00 |
| Mar 31, 2026 | -168,000.00 |
| Dec 31, 2025 | -165,000.00 |
| Dec 31, 2025 | -165,000.00 |
| Dec 31, 2025 | -165,000.00 |
| Sep 30, 2025 | -156,000.00 |
| Sep 30, 2025 | -156,000.00 |
| Sep 30, 2025 | -156,000.00 |
| Jun 30, 2025 | 72,000.00 |
| Jun 30, 2025 | 72,000.00 |
| Jun 30, 2025 | 72,000.00 |
| Mar 31, 2025 | 435,000.00 |
| Mar 31, 2025 | 435,000.00 |
| Mar 31, 2025 | 435,000.00 |
| Dec 31, 2024 | -110,000.00 |
| Dec 31, 2024 | -110,000.00 |
| Dec 31, 2024 | -110,000.00 |
| Sep 30, 2024 | -121,000.00 |
| Sep 30, 2024 | -121,000.00 |